RGLS is currently covered by 2 analysts with average potential upside of $690.62 (92.15%) backed by 11 price targets and 21 ratings. Documented since 14-Aug-2013. Analyst's average stock valuation to be materialised ratio is 30.56% with an average time for price targets to be met of 147.67 days.
Most recent stock forecast was given by LIANA MOUSSATOS from WEDBUSH on 21-Jan-2022.
Highest price target for RGLS is 9, Lowest price target is 2, average price target is 5.5.
Currently, out of the existing stock ratings of RGLS - 2 which are a Hold (66.67%), 1 which are a Buy (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
10
$9.19 (1134.57%)
10
1 years 2 months 10 days ago
2/3 (66.67%)
$212.99 (132.75%)
7
Hold
4 years 12 days ago
1/4 (25%)
$1576.8 (81.69%)
436
Hold
60
$59.19 (7307.41%)
120
4 years 8 months 25 days ago
0/4 (0%)
$282.06 (62.02%)
What is RGLS(Regulus Therapeutics Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RGLS(Regulus Therapeutics Inc) with a proven track record?
